| Th2 cells as targets for therapeutic intervention in allergic bronchial asthma |
 |
 |
|
Expert Rev Mol Diagn. 2009 Jan;9(1):85-100.
Th2 cells as targets for therapeutic intervention in allergic bronchial asthma.
Wegmann M. Bereich Experimentelle Pneumologie, Forschungszentrum Borstel, Leibniz-Zentrum für Medizin und Biowissenschaften, Parkallee 1, D-23845 Borstel, Germany. mwegmann@fz-borstel.de
Th2 cells play a central role in the pathogenesis of allergic bronchial asthma, since each of their characteristic cytokines such as IL-4, IL-5, IL-9 and IL-13 contributes to hallmarks of this disease, including airway eosinophilia, increased mucus production, production of allergen-specific IgE and development of airway hyper-responsiveness. Therefore, these cells are predisposed as target cells for therapeutic intervention. Experimental approaches targeted Th2-type effector cytokines, Th2-cell recruitment and Th2-cell development. Another strategy uses the immunomodulatory potential of tolerance-inducing cytokines such as IL-10 or of cytokines such as IL-12, IL-18 and IFN-gamma that are able to induce a counterbalancing Th1 immune response.
PMID: 19099351 [PubMed - indexed for MEDLINE]
{mosgoogle} {mos_sb_discuss:13}
Set as favorite
Bookmark
Email this
Hits: 495 Comments (0)
 Write comment
|
Subscribe to this comment's feed
Show/hide comments
Show/hide comment form
